Methylenetetrahydrofolate Reductase Gene Polymorphism as a Risk Factor for Diabetic Nephropathy in IDDM Patients

This publication has 12 references indexed in Scilit:

• Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy in NIDDM patients
  The Lancet, 1998
• Apolipoprotein E4 reduces risk of diabetic nephropathy in patients with NIDDM
  American Journal of Kidney Diseases, 1998
• Analysis of the 677 C→T Mutation of the Methylenetetrahydrofolate Reductase Gene in Different Ethnic Groups
  Thrombosis and Haemostasis, 1998
• The Mutation Ala677→Val in the Methylene Tetrahydrofolate Reductase Gene: A Risk Factor for Arterial Disease and Venous Thrombosis
  Thrombosis and Haemostasis, 1997
• Hyperhomocysteinemia:An Emerging and Important Risk Factor for Thromboembolic and Cardiovascular Disease
  American Journal of Clinical Pathology, 1996
• Homocysteine mediated endothelial cell toxicity and its amelioration
  Atherosclerosis, 1996
• Genetic susceptibility to nephropathy in insulin‐dependent diabetes: From epidemiology to molecular genetics
  Diabetes/Metabolism Research and Reviews, 1995
• A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase
  Nature Genetics, 1995
• A non-organic and non-enzymatic extraction method gives higher yields of genomic DNA from whole-blood samples than do nine other methods tested
  Journal of Biochemical and Biophysical Methods, 1992
• Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants.
  Proceedings of the National Academy of Sciences, 1977